The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials
Authors
Keywords
Bone fracture, Meta-analysis, Comparators, Network analysis, Type 2 diabetes, Bone density, Publication ethics, Randomized controlled trials
Journal
PLoS One
Volume 12, Issue 12, Pages e0187537
Publisher
Public Library of Science (PLoS)
Online
2017-12-06
DOI
10.1371/journal.pone.0187537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dipeptidyl peptidase-4 inhibitors and bone metabolism: is vitamin D the link?
- (2016) I. Barchetta et al. ACTA DIABETOLOGICA
- The use of incretins and fractures - a meta-analysis on population-based real life data
- (2016) Johanna H. M. Driessen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- DPP-4 inhibitor therapy and bone fractures in people with Type 2 diabetes – A systematic review and meta-analysis
- (2016) Jil Mamza et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation
- (2016) Daisuke Yabe et al. Expert Opinion On Drug Safety
- Omarigliptin for the treatment of type 2 diabetes mellitus
- (2016) Philip M. S. Evans et al. EXPERT OPINION ON PHARMACOTHERAPY
- Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes
- (2016) Gian Paolo Fadini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dipeptidyl peptidase-4 inhibitors and fracture risk: an updated meta-analysis of randomized clinical trials
- (2016) Jianying Fu et al. Scientific Reports
- Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs
- (2015) Johanna H. M. Driessen et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis
- (2015) Johanna H. M. Driessen et al. CALCIFIED TISSUE INTERNATIONAL
- Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial
- (2015) Ofri Mosenzon et al. DIABETES CARE
- Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus
- (2015) Kate L. Lapane et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
- (2015) Emma O. Billington et al. DIABETOLOGIA
- Diabetes mellitus and risk of hip fractures: a meta-analysis
- (2015) Y. Fan et al. OSTEOPOROSIS INTERNATIONAL
- Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis
- (2015) Gert van Valkenhoef et al. Research Synthesis Methods
- DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats
- (2014) Lorenzo Glorie et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
- (2014) Johanna H.M. Driessen et al. BONE
- Type 2 diabetes mellitus and fracture risk
- (2014) Anastasia D. Dede et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of glimepiride on the skeletal system of ovariectomized and non-ovariectomized rats
- (2014) Justyna Fronczek-Sokół et al. Pharmacological Reports
- The role of glucagon on type 2 diabetes at a glance
- (2014) Amélio F Godoy-Matos Diabetology & Metabolic Syndrome
- Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus
- (2013) Boaz Hirshberg et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Sulfonylureas and Risk of Falls and Fractures: A Systematic Review
- (2013) Kate L. Lapane et al. DRUGS & AGING
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials (胰高血糖素样肽-1受体激动剂的使用与骨折的关系：一项对随机临床试验的meta分析)
- (2013) Guillaume Mabilleau et al. Journal of Diabetes
- Dipeptidyl peptidase-4 inhibitors and prevention of bone fractures: Effects beyond glyemic control
- (2012) Daisuke Yabe et al. Journal of Diabetes Investigation
- Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
- (2012) Georgia Salanti Research Synthesis Methods
- Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression
- (2012) Ian R. White et al. Research Synthesis Methods
- Automating network meta-analysis
- (2012) Gert van Valkenhoef et al. Research Synthesis Methods
- Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- (2011) Zubair Shah et al. CIRCULATION
- Saxagliptin: A Clinical Review in the Treatment of Type 2 Diabetes Mellitus
- (2011) Deanna S. Kania et al. CLINICAL THERAPEUTICS
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- FRAX underestimates fracture risk in patients with diabetes
- (2011) Lora M Giangregorio et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*
- (2011) Mathijs C. BUNCK et al. Journal of Diabetes
- Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
- (2010) A. J. Scheen DIABETES OBESITY & METABOLISM
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway
- (2009) Pan Ma et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells
- (2008) Gerta Rücker et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now